HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer

JAMA

Volumn 283, Issue 1, 2000, Pages 81-86

  Wright, Thomas C ^a   Denny, Lynette ^d   Kuhn, Louise ^b   Pollack, Amy ^c   Lorincz, Attila ^e  

^a Coll Phys Surgs of Columbia Univ ^*  (United States)

^b Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H Sergievsky Center   (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

^d UNIVERSITY OF CAPE TOWN   (South Africa)

^e Digene Corp   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADULT; AGE; AGED; ARTICLE; CANCER GRADING; CANCER SCREENING; CHLAMYDIA TRACHOMATIS; COLPOSCOPY; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; NEISSERIA GONORRHOEAE; PAPANICOLAOU TEST; PRIORITY JOURNAL; SAMPLING; SEXUALLY TRANSMITTED DISEASE; SOUTH AFRICA; TRICHOMONAS VAGINALIS; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS;

EID: 0343048335     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.283.1.81     Document Type: Article

References (28)

1. Miller AB. Failures of cervical cancer screening. Am J Public Health. 1995;85:795.
2. Pasani P, Parkin DM, Bray F, Ferlay J. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer. 1999;83:18-29.
3. American Cancer Society. 1999 Cancer Facts and Figures. Available at: http://www.cancer.org/cff99/ selectedcancer.html. Accessed December 7, 1999.
4. Hakama M, Chamberlain J, Day NE, Miller AB, Prorok PC. Evaluation of screening programmes for gynaecological cancer. Br J Cancer. 1985;52:669-673.
5. Janerich DT, Hadjimichael O, Schwarz PE, et al. The screening histories of women with invasive cervical cancer, Connecticut. Am J Public Health. 1995;85:791-794.
6. Kinney W, Sung HY, Kearney KA, Miller M, Sawaya G, Hiatt PA. Missed opportunities for cervical cancer screening of HMO members developing invasive cervical cancer (ICC). Gynecol Oncol. 1998;71:428-430.
7. Centers for Disease Control and Prevention. Cervical cancer control, Rhode Island. MMWR Morb Mortal Wkly Rep. 1989;38:659-662.
8. Burack RC, Gimotty PA, George J, et al. How reminders given to patients and physicians affected pap smear use in a health maintenance organization. Cancer. 1998;82:2391-2400.
9. Cuzick J, Szarewski A, Terry G, et al. Human papillomavirus testing in primary cervical screening. Lancet. 1995;345:1533-1536.
10. Schneider A, Zahm DM, Kirchmayr R, Schneider VL. Screening for cervical intraepithelial neoplasia grade 2/3. Am J Obstet Gynecol. 1996;174:1534-1541.
11. Meijer CJ, Van den Brule AJ, Snijders PJF, Kenemans P, Bleker OP, Walboomers JMM. Human papillomaviruses and cervical cancer: the view of the gynaeco-pathologist. Cervix. 1992;10:101-108.
12. Megavand E, Denny L, Dehaeck K, Soeters R, Block B. Acetic acid visualization of the cervix. Obstet Gynecol. 1996;88:383-386.
13. Abrams J. A preliminary study of the gynoscope. Am J Gynecol Health. 1990;4:37-43.
14. Luff RD. The Bethesda System for reporting cervical/vaginal cytologic diagnoses. Hum Pathol. 1992; 23:719-721.
15. Solomon D, Frable WJ, Vooijs GP, et al. ASCUS and AGUS criteria. International Academy of Cytology Taskforce summary. Diagnostic Cytology Towards the 21st Century: an international expert conference and tutorial. Acta Cytol. 1998;42:16-24.
16. Reid R. Colposcopy of cervical preinvasive neoplasia. In: Singer A, ed. Premalignant Lesions of the Lower Genital Tract. New York, NY: Elsevier; 1990:87-116.
17. Chock C, Irwig L, Berry G, Glasziou P. Comparing dichotomous screening tests when individuals negative on both tests are not verified. J Clin Epidemiol. 1997;50:1211-1217.
18. Schatzkin A, Conner RJ, Taylor PR, Bunnag B. Comparing new and old screening tests when a reference procedure cannot be performed on all screens. Am J Epidemiol. 1987;125:672-678.
19. Richard RM. Screening: the next century. 1995; 76:1919-1927.
20. Sankaranarayanan R, Wesley R, Somanathan T, et al. Visual inspection of the uterine cervix after the application of acetic acid in the detection of cervical carcinoma and its precursors. Cancer. 1998;83:2150-2156.
21. Denny L, Kuhn L, Risi L, et al. Two-stage cervical cancer screening: an alternative for resource-poor settings. Am J Obstet Gynecol. In press.
22. Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System, 1997. Available at: http://www.cdc.gov/nccdphp/brfss. Accessed December 7, 1999.
23. Wawer MJ, McNaim D, Wabwire-Mangen F, Paxton L, Gray RH, Kiwanuka N. Self-administered vaginal swabs for population-based assessment of Tdchomonas vaginalis prevalence [letter]. Lancet. 1995;345:131-132.
24. Sewankambo N, Gray RH, Wawer MJ, et al. HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis [published erratum appears in Lancet. 1997;350:1036]. Lancet. 1997;350: 546-550.
25. Gray RH, Wawer MJ, Girdner J, et al. Use of self-collected vaginal swabs for detection of Chlamydia trachomatis infection. Sex Transm Dis. 1998;25:450.
26. Polaneczky M, Quigley C, Pollock L, Dulko D, Witkin SS. Use of self-collected vaginal specimens for detection of Chlamydia trachomatis infection. Obstet Gynecol. 1998;91:375-378.
27. Rozendaal L, Walboomers JM, van der Linden JC, et al. PCR-based high-risk HPV test in cervical cancer screening gives objective risk assessment of women with cytomorphologically normal cervical smears. Int J Cancer. 1996;68:766-769.
28. Meijer CJ, van den Brule AJ, Snijders PJ, Helmerhorst T, Kenemans P, Walboomers JM. Detection of human papillomavirus in cervical scrapes by the polymerase chain reaction in relation to cytology: possible implications for cervical cancer screening. IARC Sci Publ. 1992:271-282.